Kiwa Bio-Tech Products Group Corporation
Kiwa Bio-Tech Products Group Corporation (KWBT) Stock Overview
Explore Kiwa Bio-Tech Products Group Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
56.5K
P/E Ratio
-0.00
EPS (TTM)
$-0.29
ROE
-0.59%
KWBT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Kiwa Bio-Tech Products Group Corporation (KWBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 56.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.
Ziqi Wang
16
International Agriculture Innovation Hub, Yangling
2002